Genetic Basis of Immunodeficiency

Status Recruiting

Clinical Trial Summary

This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID). Patients with immunodeficiencies may be eligible for this study. Candidates include: - Patients with diminished numbers of T cells or NK cells or both, or - Patients with normal T cell and NK cell numbers but diminished T cell, B cell, or NK cell function. Relatives of patients will also be studied. Participants will have blood samples collected for genetic analysis in studies related to SCID at the National Institutes of Health and other institutions. ...

Clinical Trial Description

The goal of this project is to identify the genetic basis of new forms of inherited immunodeficiency. The particular focus relates to cytokines such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 that share the common cytokine receptor (Gamma) chain, (Gamma c), and to molecules that are important for signaling or gene regulation in response to these cytokines, although other causes of inherited immunodeficiency are also encompassed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00055172
Study type	Observational
Source	National Institutes of Health Clinical Center (CC)
Contact	Warren J Leonard, M.D.
Phone	(301) 496-0098
Email	wl2w@nih.gov
Status	Recruiting
Phase
Start date	April 5, 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00006335` - Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID	N/A
Not yet recruiting	`NCT02231983` - Clinical Characteristics and Genetic Profiles of Severe Combined Immunodeficiency in China	N/A
Active, not recruiting	`NCT03597594` - Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)	Phase 1/Phase 2
Completed	`NCT00000603` - Cord Blood Stem Cell Transplantation Study (COBLT)	Phase 2
Completed	`NCT00001255` - Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study	N/A
Recruiting	`NCT05651113` - The Experience of Screening for SCID
Completed	`NCT00794508` - MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID	Phase 2
Recruiting	`NCT03538899` - Autologous Gene Therapy for Artemis-Deficient SCID	Phase 1/Phase 2
Recruiting	`NCT05298930` - Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation	N/A
Recruiting	`NCT01821781` - Immune Disorder HSCT Protocol	Phase 2
Completed	`NCT00845416` - Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population	N/A
Terminated	`NCT00006054` - Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies	N/A
Completed	`NCT03878069` - Registry Study of Revcovi Treatment in Patients With ADA-SCID
Recruiting	`NCT01019876` - Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases	Phase 2/Phase 3
Completed	`NCT03513328` - Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation	Phase 1/Phase 2
Withdrawn	`NCT02177760` - Sirolimus Prophylaxis for aGVHD in TME SCID	Phase 2
Recruiting	`NCT00695279` - Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
Completed	`NCT01420627` - EZN-2279 in Patients With ADA-SCID	Phase 3
Terminated	`NCT02127892` - SCID Bu/Flu/ATG Study With T Cell Depletion	Phase 1/Phase 2
Completed	`NCT04246840` - Study Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow Allograft